ATE380792T1 - Verfahren zur herstellung von pyrrolidinoximen - Google Patents

Verfahren zur herstellung von pyrrolidinoximen

Info

Publication number
ATE380792T1
ATE380792T1 AT05708062T AT05708062T ATE380792T1 AT E380792 T1 ATE380792 T1 AT E380792T1 AT 05708062 T AT05708062 T AT 05708062T AT 05708062 T AT05708062 T AT 05708062T AT E380792 T1 ATE380792 T1 AT E380792T1
Authority
AT
Austria
Prior art keywords
oximes
pyrrolidine oximes
producing pyrrolidine
producing
formula
Prior art date
Application number
AT05708062T
Other languages
English (en)
Inventor
William Nadler
Doris Pupowicz
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE380792T1 publication Critical patent/ATE380792T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05708062T 2004-02-26 2005-02-28 Verfahren zur herstellung von pyrrolidinoximen ATE380792T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04100773 2004-02-26

Publications (1)

Publication Number Publication Date
ATE380792T1 true ATE380792T1 (de) 2007-12-15

Family

ID=34896105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05708062T ATE380792T1 (de) 2004-02-26 2005-02-28 Verfahren zur herstellung von pyrrolidinoximen

Country Status (21)

Country Link
US (1) US20070197794A1 (de)
EP (1) EP1725526B1 (de)
JP (1) JP2007524702A (de)
KR (1) KR20060124775A (de)
CN (1) CN1946686A (de)
AT (1) ATE380792T1 (de)
AU (1) AU2005217153A1 (de)
BR (1) BRPI0508059A (de)
CA (1) CA2554767A1 (de)
CY (1) CY1107139T1 (de)
DE (1) DE602005003803T2 (de)
DK (1) DK1725526T3 (de)
EA (1) EA011026B1 (de)
ES (1) ES2296137T3 (de)
IL (1) IL177388A0 (de)
NO (1) NO20064352L (de)
PL (1) PL1725526T3 (de)
PT (1) PT1725526E (de)
SI (1) SI1725526T1 (de)
UA (1) UA86226C2 (de)
WO (1) WO2005082848A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845850A1 (de) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidinderivate als Oxytocin/Vasopressin-V1a-Rezeptorantagonisten
EP2886107A1 (de) 2013-12-17 2015-06-24 ObsEva S.A. Orale Formulierungen von Pyrrolydinderivaten
CN114105851A (zh) 2014-07-02 2022-03-01 奥布赛瓦股份公司 治疗ot-r活性相关的病症的方法中可用的晶体
WO2021165927A1 (en) * 2020-02-21 2021-08-26 Wockhardt Bio Ag 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329418B1 (en) * 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
HK1054031B (zh) * 2000-03-27 2007-05-04 Merck Serono Sa 具有药物活性的吡咯烷衍生物
RS99503A (sr) * 2001-06-18 2006-12-15 Applied Research Systems Ars Holding N.V. Derivati pirolidin oksadiazola i tiadiazola

Also Published As

Publication number Publication date
PT1725526E (pt) 2007-12-27
NO20064352L (no) 2006-09-26
CY1107139T1 (el) 2012-10-24
JP2007524702A (ja) 2007-08-30
DE602005003803T2 (de) 2008-12-24
IL177388A0 (en) 2006-12-10
DK1725526T3 (da) 2008-03-03
UA86226C2 (en) 2009-04-10
CA2554767A1 (en) 2005-09-09
KR20060124775A (ko) 2006-12-05
ES2296137T3 (es) 2008-04-16
EA011026B1 (ru) 2008-12-30
US20070197794A1 (en) 2007-08-23
EP1725526B1 (de) 2007-12-12
WO2005082848A3 (en) 2005-12-01
BRPI0508059A (pt) 2007-07-17
CN1946686A (zh) 2007-04-11
AU2005217153A1 (en) 2005-09-09
PL1725526T3 (pl) 2008-03-31
EA200601456A1 (ru) 2007-02-27
SI1725526T1 (sl) 2008-04-30
DE602005003803D1 (de) 2008-01-24
WO2005082848A2 (en) 2005-09-09
EP1725526A2 (de) 2006-11-29

Similar Documents

Publication Publication Date Title
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
ATE455763T1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
ATE548353T1 (de) Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE03713610T1 (de) Neue kristallformen von atorvastatin-hemicalcium und verfahren zu deren herstellung, sowie neue verfahren zur herstellung der formen i, viii und ix von atorvastatin-hemicalcium
ATE486841T1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
DE602006003393D1 (de) Verfahren zur Herstellung von Synthesegas durch Dampfreformieren und partielle Oxidation
DE60316152D1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
ATE401300T1 (de) Verfahren zur herstellung von valsartan und vorstufen davon
CY1107139T1 (el) Μεθοδος παρασκευης πυρρολιδινοξιμων
DE60308066D1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
ATE517078T1 (de) Verfahren zur herstellung von benzophenoniminen
TW200635905A (en) Processes for producing 4-aminoquinazolines
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE341558T1 (de) Verfahren zur herstellung von topiramate
DE502005009501D1 (de) Verfahren zur herstellung von candesartan
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE427297T1 (de) Verfahren zur herstellung von beta- aminopropionsaurederivaten
ATE488492T1 (de) Verfahren zur herstellung von gabapentin
DE602004031727D1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1725526

Country of ref document: EP

REN Ceased due to non-payment of the annual fee